25-Hydroxyvitamin D3 and 1,25-Dihydroxyvitamin D3 Promote the Differentiation of Human Subcutaneous Preadipocytes

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Nimitphong, Hataikarn ^a,b   Holick, Michael F ^b   Fried, Susan K ^b   Lee, Mi Jeong ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; BIOLOGICAL MARKER; CALCIFEDIOL; CALCITRIOL; CIGLITAZONE; CYTOCHROME P450; CYTOCHROME P450 24A1; MESSENGER RNA; OXYGENASE; ROSIGLITAZONE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ADIPOCYTE; ADIPOGENESIS; ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYP27B1 GENE; DRUG ACTIVITY; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMAN VERSUS ANIMAL COMPARISON; MALE; MOUSE; NONHUMAN; PROADIPOCYTE; PROTEIN EXPRESSION; PROTEIN TARGETING; SUBCUTANEOUS FAT; SUBCUTANEOUS PREADIPOCYTE; TISSUE GROWTH; VDR GENE; VITAMIN D METABOLISM;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ADIPOCYTES; ADIPOGENESIS; ADULT; ANIMALS; CALCIFEDIOL; CALCITRIOL; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MICE; RECEPTORS, CALCITRIOL; STEROID HYDROXYLASES; SUBCUTANEOUS TISSUE; THIAZOLIDINEDIONES;

EID: 84871272732     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052171     Document Type: Article

References (37)

1. Nagpal S, Na S, Rathnachalam R, (2005) Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26: 662-687.
2. Samuel S, Sitrin MD, (2008) Vitamin D's role in cell proliferation and differentiation. Nutr Rev 66: S116-S124.
3. Blumberg JM, Tzameli I, Astapova I, Lam FS, Flier JS, et al. (2006) Complex role of the vitamin D receptor and its ligand in adipogenesis in 3T3-L1 cells. J Biol Chem 281: 11205-11213.
4. Kong J, Li YC, (2006) Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells. Am J Physiol Endocrinol Metab 290: E916-E924.
5. Shi H, Norman AW, Okamura WH, Sen A, Zemel MB, (2001) 1alpha,25-Dihydroxyvitamin D3 modulates human adipocyte metabolism via nongenomic action. FASEB J 15: 2751-2753.
6. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, et al. (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 1770-1773.
7. Sigmundsdottir H, Pan J, Debes GF, Alt C, Habtezion A, et al. (2007) DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat Immunol 8: 285-293.
8. Lahnalampi M, Heinaniemi M, Sinkkonen L, Wabitsch M, Carlberg C, (2010) Time-resolved expression profiling of the nuclear receptor superfamily in human adipogenesis. PLoS One 5: e12991.
9. Li J, Byrne ME, Chang E, Jiang Y, Donkin SS, et al. (2008) 1alpha,25-Dihydroxyvitamin D hydroxylase in adipocytes. J Steroid Biochem Mol Biol 112: 122-126.
10. White UA, Stephens JM, (2010) Transcriptional factors that promote formation of white adipose tissue. Mol Cell Endocrinol 318: 10-14.
11. Farmer SR, (2006) Transcriptional control of adipocyte formation. Cell Metab 4: 263-273.
12. Yang RZ, Lee MJ, Hu H, Pray J, Wu HB, et al. (2006) Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 290: E1253-E1261.
13. Hauner H, Skurk T, Wabitsch M, (2001) Cultures of human adipose precursor cells. Methods Mol Biol 155: 239-247.
14. Tchkonia T, Lenburg M, Thomou T, Giorgadze N, Frampton G, et al. (2007) Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns. Am J Physiol Endocrinol Metab 292: E298-E307.
15. Lee MJ, Wu Y, Fried SK (2012) A Modified Protocol to Maximize Differentiation of Human Preadipocytes and Improve Metabolic Phenotypes. Obesity (Silver Spring). Obesity (Silver Spring). 2012 May 4. doi: 10.1038/oby.2012.116. [Epub ahead of print].
16. Siersbaek R, Nielsen R, John S, Sung MH, Baek S, et al. (2011) Extensive chromatin remodelling and establishment of transcription factor 'hotspots' during early adipogenesis. EMBO J 30: 1459-1472.
17. Yang HN, Park JS, Woo DG, Jeon SY, Do HJ, et al. (2011) C/EBP-alpha and C/EBP-beta-mediated adipogenesis of human mesenchymal stem cells (hMSCs) using PLGA nanoparticles complexed with poly(ethyleneimmine). Biomaterials 32: 5924-5933.
18. Kelly KA, Gimble JM, (1998) 1,25-Dihydroxy vitamin D3 inhibits adipocyte differentiation and gene expression in murine bone marrow stromal cell clones and primary cultures. Endocrinology 139: 2622-2628.
19. Tontonoz P, Spiegelman BM, (2008) Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem 77: 289-312.
20. Wood RJ, (2008) Vitamin D and adipogenesis: new molecular insights. Nutr Rev 66: 40-46.
21. Narvaez CJ, Matthews D, Broun E, Chan M, Welsh J, (2009) Lean phenotype and resistance to diet-induced obesity in vitamin D receptor knockout mice correlates with induction of uncoupling protein-1 in white adipose tissue. Endocrinology 150: 651-661.
22. Wong KE, Szeto FL, Zhang W, Ye H, Kong J, et al. (2009) Involvement of the vitamin D receptor in energy metabolism: regulation of uncoupling proteins. Am J Physiol Endocrinol Metab 296: E820-E828.
23. Wong KE, Kong J, Zhang W, Szeto FL, Ye H, et al. (2011) Targeted expression of human vitamin D receptor in adipocytes decreases energy expenditure and induces obesity in mice. J Biol Chem 286: 33804-33810.
24. Butler AA, Kozak LP, (2010) A recurring problem with the analysis of energy expenditure in genetic models expressing lean and obese phenotypes. Diabetes 59: 323-329.
25. Tschop MH, Speakman JR, Arch JR, Auwerx J, Bruning JC, et al. (2012) A guide to analysis of mouse energy metabolism. Nat Methods 9: 57-63.
26. Deluca HF, Prahl JM, Plum LA, (2011) 1,25-Dihydroxyvitamin D is not responsible for toxicity caused by vitamin D or 25-hydroxyvitamin D. Arch Biochem Biophys. 505: 226-230.
27. Lou YR, Molnar F, Perakyla M, Qiao S, Kalueff AV, et al. (2010) 25-Hydroxyvitamin D(3) is an agonistic vitamin D receptor ligand. J Steroid Biochem Mol Biol 118: 162-170.
28. Monkawa T, Yoshida T, Hayashi M, Saruta T, (2000) Identification of 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression in macrophages. Kidney Int 58: 559-568.
29. Overbergh L, Decallonne B, Valckx D, Verstuyf A, Depovere J, et al. (2000) Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin Exp Immunol 120: 139-146.
30. Zehnder D, Bland R, Chana RS, Wheeler DC, Howie AJ, et al. (2002) Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol 13: 621-629.
31. Ching S, Kashinkunti S, Niehaus MD, Zinser GM, (2011) Mammary adipocytes bioactivate 25-hydroxyvitamin D(3) and signal via vitamin D(3) receptor, modulating mammary epithelial cell growth. J Cell Biochem. 112: 3393-405.
32. Lorente-Cebrian S, Eriksson A, Dunlop T, Mejhert N, Dahlman I, et al. (2011) Differential effects of 1alpha,25-dihydroxycholecalciferol on MCP-1 and adiponectin production in human white adipocytes. Eur J Nutr. 51: 335-42.
33. Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, et al. (2008) Dynamics of fat cell turnover in humans. Nature 453: 783-787.
34. Lenders CM, Feldman HA, Von SE, Merewood A, Sweeney C, et al. (2009) Relation of body fat indexes to vitamin D status and deficiency among obese adolescents. Am J Clin Nutr 90: 459-467.
35. Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, et al. (2008) Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr 88: 1519-1527.
36. Valina-Toth AL, Lai Z, Yoo W, Abou-Samra A, Gadegbeku CA, et al. (2010) Relationship of vitamin D and parathyroid hormone with obesity and body composition in African Americans. Clin Endocrinol (Oxf) 72: 595-603.
37. Mitri J, Dawson-Hughes B, Hu FB, Pittas AG, (2011) Effects of vitamin D and calcium supplementation on pancreatic {beta} cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 94: 486-494.